Premium
Letter to the Editor: Cilofexor in Patients With Nonalcoholic Steatohepatitis (NASH): Is It Really Effective?
Author(s) -
Jindal Ankur,
Sarin Shiv K.
Publication year - 2020
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.31400
Subject(s) - farnesoid x receptor , obeticholic acid , medicine , gadoxetic acid , bile acid , nonalcoholic steatohepatitis , liver biopsy , steatosis , gastroenterology , nonalcoholic fatty liver disease , agonist , magnetic resonance imaging , biopsy , fatty liver , disease , receptor , radiology , nuclear receptor , chemistry , biochemistry , transcription factor , gadolinium dtpa , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom